ArticleOncotarget2018

T-lymphokine-activated killer cell-originated protein kinase (TOPK) as a prognostic factor and a potential therapeutic target in glioma.

Chuntao Quan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.